Day: November 17, 2021

QUEBEC CITY, Nov. 17, 2021 (GLOBE NEWSWIRE) — LeddarTech^®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce its participation as a host and co-presenter at various events in December. These events will showcase LeddarTech’s comprehensive end-to-end technology platforms, which enable customers to solve critical sensing and perception challenges across the entire value chain of the automotive, mobility and off-road markets. The featured solutions include the LeddarVision™ sensor fusion and perception platform for Tier 1s and OEMs and the cost-effective, scalable LiDAR XLRator development solution based on patented LeddarEngine™ technology designed for LiDAR makers and Tier 1-2 manufacturers.

December 2, 2021: The Autonomous, a global member-only organization that comprises technology companies committed to working together in shaping the future of autonomous driving, hosts LeddarTech at this exclusive virtual event:

“Reimagining Autonomy: A Platform Approach”

A stellar lineup of partners will come together to explore the ADAS and AD landscape, the challenges and the emerging technologies that are positioned to solve these challenges. This event will consist of keynote presentations, panel discussions and a roundtable deep dive session.

Presenters:

• Frantz Saintellemy, President and COO from LeddarTech
• Marco Angelici, MEMS Micro Actuators Business Unit Director from STMicroelectronics
• Thomas Brandes, Senior Marketing Manager for Visible and IR Lasers from ams OSRAM Group
• Eric Hoarau, Head of Automotive Strategic Partnerships from Flex

Register for these limited tickets at this virtual event here.

December 6, 2021: All About Circuits, a leader in tech media, hosts LeddarTech and Omni Design for a global webinar:

“Are Solid-State LiDARs Ready for Mass-Market Deployment?”

LeddarTech and Omni Design are collaborating to address this market requirement to enable mass production of solid-state LiDAR products that meet stringent automotive requirements and provide exceptional performance and significantly lower cost and power consumption while enabling a smaller form factor and faster time-to-market.

Presenters:

• Pierre Olivier, Chief Technology Officer of LeddarTech
• Dr. Manar El-Chammas, Vice President of Engineering at Omni Design Technologies

Pierre and Manar will share the synergy of solutions between the two organizations and jointly describe how they collaborate, synergistic benefits to LiDAR manufacturers and Tier 1 suppliers and the roadmap for collaboration.

Register for this virtual event here.

December 9, 2021: Reuters Events, a division of the international Reuters news organization, will be hosting LeddarTech at this global event:

“Sensor Fusion and Perception Solutions for Critical ADAS and AD Applications”

In this exclusive hands-on workshop, LeddarTech and guests will explore why perception software is a crucial enabler and accelerator of ADAS and AD in Level 1-5. While perception continues to represent a big challenge for automakers as they advance to the next levels of autonomy, this workshop will discuss how raw data fusion and perception software can accelerate this advancement by more than three years.

Presenters:

• Pierre Olivier, Chief Technology Officer of LeddarTech
• Stav Yoffe, Senior Product Manager, Sensor Fusion of LeddarTech

Register for limited tickets for this virtual event here.

For a complete list of LeddarTech’s upcoming live and virtual events, including CES 2022, please visit leddartech.com/events.

About LeddarTech
LeddarTech provides the most flexible, robust and accurate ADAS and AD sensing technology for autonomous vehicles and advanced driver assistance systems. Founded in 2007, LeddarTech has evolved to become a comprehensive end-to-end environmental sensing company by enabling customers to solve critical sensing, fusion and perception challenges across the entire value chain. The company offers cost-effective and scalable solutions such as LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model with multi-sensor support for camera, radar and LiDAR configurations. It is scalable to support all vehicle automation levels. In addition, LeddarTech supports LiDAR makers and Tier 1-2 automotive system integrators with LeddarSteer™, a digital beam steering device, and the LiDAR XLRator development solution for automotive-grade solid-state LiDAR development based on the LeddarEngine™ and core components from global semiconductor partners. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 100 patented technologies (granted or pending) enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Product Management, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

เมืองควิเบก, Nov. 17, 2021 (GLOBE NEWSWIRE) — LeddarTech^®ผู้นำระดับโลกด้านการให้บริการระบบเทคโนโลยีเซ็นเซอร์ ADAS และ AD ที่ยืดหยุ่น ทนทาน และแม่นยำ มีความยินดีที่จะประกาศการร่วมเป็นเจ้าภาพและผู้ร่วมนำเสนองานกิจกรรมต่าง ๆ ในเดือนธันวาคม งานกิจกรรมเหล่านี้จะจัดแสดงแพลตฟอร์มเทคโนโลยีแบบครบวงจรที่ครอบคลุมของ LeddarTech ซึ่งช่วยให้ลูกค้าสามารถแก้ปัญหาความท้าทายเกี่ยวกับเซ็นเซอร์ละการรับสัญญาณที่เกิดขึ้นในกระบวนการการตลาดของรถยนต์ ยานยนต์ และรถออฟโรดทั้งหมด โซลูชันเด่น ๆ ได้แก่ ผลงานของLeddarVision™ ที่เป็นการผสานเซ็นเซอร์และแพลตฟอร์มการรับสัญญาณสำหรับโซลูชันการพัฒนา LiDAR XLRator ระดับ 1 และ OEM ที่คุ้มค่าและปรับขนาดได้ตามเทคโนโลยี จากLeddarEngine™ ที่ได้รับสิทธิบัตรซึ่งออกแบบมาสำหรับผู้ผลิต LiDAR และผู้ผลิตระดับ 1-2

2 ธันวาคม 2021: The Autonomous องค์กรระดับโลกสงวนไว้เฉพาะสมาชิกอันประกอบด้วยบริษัทด้านเทคโนโลยีต่าง ๆ ที่มุ่งมั่นทำงานร่วมกันเพื่อสร้างอนาคตของการขับขี่แบบอัตโนมัติ เป็นเจ้าภาพให้กับ LeddarTech ในงานกิจกรรมแบบเสมือนสุดพิเศษนี้

“การจินตนาการใหม่ถึงยานยนต์ที่ขับเคลื่อนแบบอัตโนมัติ: แนวทางของแพลตฟอร์ม”

กลุ่มพันธมิตรสำคัญจะมารวมตัวกันเพื่อสำรวจภูมิทัศน์ของ ADAS และ AD ความท้าทายและเทคโนโลยีที่เกิดขึ้นใหม่ซึ่งอยู่ในจุดที่จะแก้ปัญหาความท้าทายเหล่านี้ งานนี้จะประกอบด้วยการนำเสนอประเด็นสำคัญ การอภิปรายแบบกลุ่ม และช่วงการหารือโต๊ะกลมแบบเจาะลึก

ผู้นำเสนอ:

• Frantz Saintellemy ประธานและ COO จาก LeddarTech
• Marco Angelici ผู้อำนวยการหน่วยธุรกิจ MEMS Micro Actuators จาก STMicroelectronics
• Thomas Brandes ผู้จัดการฝ่ายการตลาดอาวุโสสำหรับ Visible และ IR Lasers จาก ams OSRAM Group
• Eric Hoarau หัวหน้าฝ่ายพันธมิตรด้านกลยุทธ์ยานยนต์จาก Flex

ลงทะเบียนสำหรับบัตรเข้าชมที่มีจำนวนจำกัดในงานกิจกรรมเสมือนจริงนี้ ที่นี่

6  ธันวาคม 2021: All About Circuitsผู้นำด้านสื่อเทคโนโลยี เป็นเจ้าภาพให้กับ LeddarTech และ Omni Design จัดงานสัมมนาผ่านเว็บระดับโลก:

“Solid-State LiDARs พร้อมใช้งานในตลาดมวลชนหรือยัง”

LeddarTech และ Omni Design  ร่วมมือกัน กล่าวถึงความต้องการของตลาดนี้ เพื่อให้สามารถผลิตผลิตภัณฑ์ solid-state LiDAR ในปริมาณมากที่ตรงตามข้อกำหนดด้านยานยนต์ที่เข้มงวด และให้ประสิทธิภาพที่ยอดเยี่ยม ลดต้นทุนและการใช้พลังงานลงอย่างมาก ในขณะที่เปิดใช้งานฟอร์มแฟกเตอร์ที่เล็กลงและออกสู่ตลาดได้เร็วขึ้น

ผู้นำเสนอ:

• Pierre Olivier ประธานเจ้าหน้าที่ฝ่ายเทคโนโลยีของ LeddarTech
• Dr. Manar El-Chammas รองประธานฝ่ายวิศวกรรมของ Omni Design Technologies

Pierre และ Manar จะมาแบ่งปันการผสานความสามารถของโซลูชันจากทั้งสององค์กร และอธิบายถึงการทำงานร่วมกัน ผลประโยชน์ร่วมกันกับผู้ผลิต LiDAR และซัพพลายเออร์ระดับ 1 รวมถึงแผนงานความร่วมมือ

ลงทะเบียนสำหรับงานกิจกรรมเสมือนจริงนี้ ที่นี่

9 ธันวาคม 2021: Reuters Events แผนกหนึ่งขององค์กรข่าวของ Reuters ระหว่างประเทศ จะเป็นเจ้าภาพ LeddarTech ในงานระดับโลกนี้:

“โซลูชันฟิวชันเซ็นเซอร์และการรับสัญญาณสำหรับแอปพลิเคชัน ADAS และ AD ที่สำคัญ”

ในประชุมเชิงปฏิบัติสุดพิเศษนี้ LeddarTech และผู้ร่วมงานจะสำรวจว่าเหตุใดซอฟต์แวร์การรับสัญญาณจึงเป็นตัวเปิดใช้งานและตัวเร่งที่สำคัญของ ADAS และ AD ในระดับ 1-5 ในขณะที่การรับสัญญาณยังคงเป็นความท้าทายที่ยิ่งใหญ่สำหรับผู้ผลิตรถยนต์ที่ก้าวเข้าสู่ระดับต่อไปของการขับเคลื่อนแบบอัตโนมัติ การประชุมเชิงปฏิบัติการนี้จะหารือว่าซอฟต์แวร์ผสานข้อมูลดิบและการรับสัญญาณสามารถเร่งความก้าวหน้านี้ได้เร็วขึ้นกว่าสามปีได้อย่างไร

ผู้นำเสนอ:

• Pierre Olivier ประธานเจ้าหน้าที่ฝ่ายเทคโนโลยีของ LeddarTech
• Stav Yoffe ผู้จัดการผลิตภัณฑ์อาวุโส Sensor Fusion ของ LeddarTech

ลงทะเบียนสำหรับบัตรเข้าชมที่มีจำนวนจำกัดเหล่านี้ในงานกิจกรรมเสมือนจริงนี้ ที่นี่

ดูรายการกิจกรรมสดและงานกิจกรรมเสมือนจริงที่กำลังจะเกิดขึ้นของ LeddarTech รวมถึง CES 2022 ได้ที่ leddartech.com/events

เกี่ยวกับ LeddarTech
LeddarTech นำเสนอเทคโนโลยีการตรวจวัดระบบ ADAS และ AD ที่ยืดหยุ่น แข็งแกร่ง และแม่นยำที่สุดสำหรับรถยนต์ขับเคลื่อนอัตโนมัติและระบบช่วยเหลือผู้ขับขี่ขั้นสูง LeddarTech ก่อตั้งขึ้นในปี 2007 และได้พัฒนาจนกลายเป็นบริษัทตรวจวัดสิ่งแวดล้อมแบบครบวงจรโดยช่วยให้ลูกค้าสามารถแก้ปัญหาด้านการตรวจวัด การผสาน และการรับสัญญาณที่สำคัญซึ่งครอบคลุมทั้งกระบวนการการตลาด บริษัทนำเสนอโซลูชันที่คุ้มค่าใช้จ่ายและปรับขนาดได้ เช่น LeddarVision™ การผสานเซ็นเซอร์ข้อมูลดิบและแพลตฟอร์มการรับสัญญาณที่สร้างแบบจำลองสิ่งแวดล้อม 3 มิติที่ครอบคลุม พร้อมรองรับเซ็นเซอร์หลายตัวสำหรับการกำหนดค่ากล้อง เรดาร์ และ LiDAR สามารถปรับขนาดเพื่อรองรับระบบอัตโนมัติของยานพาหนะทุกระดับ นอกจากนี้ LeddarTech ยังสนับสนุนผู้ผลิต LiDAR และผู้ผสานรวมระบบยานยนต์ระดับ 1-2 ด้วย LeddarSteer™ อุปกรณ์บังคับเลี้ยวด้วยลำแสงดิจิทัล และโซลูชันการพัฒนา LiDAR XLRator สำหรับการพัฒนา LiDAR แบบ solid-state ในระดับที่มีการขับเคลื่อนอัตโนมัติจาก LeddarEngine™ และส่วนประกอบหลักจากพันธมิตรเซมิคอนดักเตอร์ทั่วโลก บริษัทรับผิดชอบด้านนวัตกรรมหลายอย่างในแอปพลิเคชันการตรวจจับระยะไกลสำหรับยานยนต์และการเคลื่อนไหวที่ล้ำสมัย ด้วยเทคโนโลยีที่จดสิทธิบัตรมากกว่า 100 รายการ (ที่ได้รับหรืออยู่ระหว่างดำเนินการ) ที่ช่วยเสริม ADAS และความสามารถในการขับขี่อัตโนมัติ

ดูข้อมูลเพิ่มเติมเกี่ยวกับ LeddarTech ได้ที่ www.leddartech.com และบน LinkedIn, Twitter, Facebook และ YouTube

ติดต่อ:
Daniel Aitken รองประธานฝ่ายการตลาดระดับโลก การสื่อสารและการจัดการผลิตภัณฑ์ LeddarTech Inc.
โทร: + 1-418-653-9000 ต่อ 232
daniel.aitken@leddartech.com

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, VAYADrive, VayaVision, XLRator และโลโก้ที่เกี่ยวข้องเป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนของ LeddarTech Inc. และบริษัทในเครือ แบรนด์ ชื่อผลิตภัณฑ์และเครื่องหมายอื่น ๆ ทั้งหมดเป็นหรืออาจเป็นเครื่องหมายการค้า หรือเครื่องหมายการค้าจดทะเบียนที่ใช้เพื่อระบุผลิตภัณฑ์หรือบริการของเจ้าของที่เกี่ยวข้อง

New Orleans, LA /New York, NY, Nov. 16, 2021 (GLOBE NEWSWIRE) — New Orleans, LA/ New York, NY –Trahan Architects, a global architecture firm with studios in New Orleans and New York City, announced today that its founder and CEO, Victor F. “Trey” Trahan, III, FAIA, has been selected as the 2021 Laureate for The American Prize for Architecture by The Chicago Athenaeum: Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies.

The Chicago Athenaeum additionally recognized two Trahan Architects projects for American Architecture Awards—the Ochsner Center for Innovation and the New England Mixed-Use Development.

“Kindness and compassion are exactly what best exemplify the works of Victor F. “Trey” Trahan, III, FAIA,” stated Christian Narkiewicz-Laine, architecture critic and museum president/CEO of The Chicago Athenaeum. “Over the past three decades, Trahan’s buildings have demonstrated a combination of those qualities of talent, vision and commitment that have produced consistent and significant contributions to humanity and to the built environment through the art of architecture. They have had the unique capacity to convey seemingly conflicting characteristics—power and modesty, boldness and subtlety, public authority and bravado, and at the same time, a sense of humble intimacy.”

Narkiewicz-Laine continued, “The work is powerfully honest and authentic—sublime masterpieces of sincerity, erudition, steeped in a thorough knowledge of the discipline of architecture, and aspirations of profound cultural awareness. His built work gives opportunity and equality to the less privileged, mitigates the effects of natural disasters, reduces energy consumption, follows a resolute humanitarian agenda with the highest criteria and social objectives, and provides spaces that, at their best, welcome the public at large. Innovative and inspiring, he shows how architecture can and should improve people’s lives and impact our otherwise ordinary existence—lifting us far and beyond the hectic and chaotic nature of our time, place and cities. In this decade, this is an architect that deserves even greater professional and public accolade.”

The Award, organized jointly by two public institutions, The Chicago Athenaeum: Museum of Architecture and Design and The European Centre for Architecture Art Design and Urban Studies, honors American architects, as well as other global architects practicing on multiple continents, whose body of architectural work, over time, exemplifies superior design and humanist ideals. The American Prize for Architecture pays tribute to the spirit of the founder of modernism, Louis Sullivan, and the subsequent generations of Chicago practitioners such as Frank Lloyd Wright, Daniel H. Burnham and Holabird & Root. It also broadcasts globally the significant contributions of America’s rich and inspiring architecture practice and its living legacy to the world at large.

“To be selected as the 2021 Laureate for the American Prize for Architecture by the Chicago Athenaeum’s International Advisory Committee and for two of our projects to be awarded The American Prize for Architecture is an honor,” said Trahan. “These awards exemplify our ethos and commitment to rootedness, artistry, materiality and our responsibility to designing for spatial equity.”

Previous Laureates include Sir Norman Foster, Michael Graves, the General Services Administration, Richard Meier, Adrian Smith + Gordon Gill Architecture, Form4Architecture, James von Klemperer of Kohn Pedersen Fox Associates PC., and Bernardo Fort-Brescia and Laurinda Spear of Miami-based firm Arquitectonica. Last year, the Prize was given to Eric Owen Moss.

“Trahan epitomizes the revival of a more poetically and intellectually engaged architect who advocates for the role of the architect as being challenged to serve greater social, cultural and humanitarian needs and concerns of our civilization and society,” said Narkiewicz-Laine. “Each of Trahan’s buildings shows a precise understanding of how people will use the facility, the thoughtful and appropriate use of materials and a commitment to creating public spaces to benefit the larger community. By his professional example, he has so meaningfully expanded the role of the architect. Few in this profession, particularly today, have risen to the demands of practicing architecture as an artful endeavor. This is an architect who wholeheartedly believes in the poetic simplicity of materials and place-making, never leaving an architect’s heavy-handed fingerprint on the design concept, intent or outcome. For the inspiration he provides, through his complex, intellectual example and his rich contributions to architecture and humanity past and future, Trey Trahan is the recipient of the 2021 American Prize for Architecture.”

Trahan Architects was founded by Trahan on the belief that the mindful design of everyday spaces can elevate the human experience. It is a multi-disciplinary firm ranked the number one design firm by Architect 50, the annual ranking by Architect Magazine, the official publication of American Institute of Architects, which topped the list by building “dramatic, sumptuous and well-detailed projects.” Trahan Architects has received over a hundred national, regional and local awards, as well as several international design competitions, including five National AIA Awards.

Attachments

• Chicago Athenaeum American Prize for Architecture – New England Mixed-Use Development
• Chicago Athenaeum American Prize for Architecture- Ochsner Center for Innovation

Julia LeBlanc
Trahan Architects
4152156517
jleblanc@trahanarchitects.com

The group includes the remaining players and family members of the Afghanistan National Youth Women’s Soccer Team, people that worked for the Portuguese military and families referred by JRS Portugal

NEW YORK and LISBON, Portugal, Nov. 16, 2021 (GLOBE NEWSWIRE) — Jesuit Refugee Service Portugal (JRS Portugal) and The Romulus T. Weatherman Foundation (The Foundation) of New York are pleased to announce the rescue of and granting of asylum to Portugal of 220 Afghan nationals. The group includes the remaining 115 players and family members of the Afghanistan National Youth Women’s Soccer Team, and individuals who aided Portugal, Germany, and Estonia as well as families referred by JRS Portugal.

The rescue of the soccer players and their families began in August with an operation underwritten in entirety by The Romulus T. Weatherman Foundation. With The Foundation’s financial backing, the families were brought to safe houses in Afghanistan and flown to Lisbon. Andrew P. Duncan, co-head of The Foundation, facilitated and oversaw the rescue from Portugal and has spent eight weeks helping to resettle the Afghans and integrate them into Portuguese society. Due to the lack of funding from the European Union, The Foundation supplied the funds necessary to ensure safe resettlement of the Afghans.

The Foundation had previously facilitated and underwritten the safe evacuation and resettlement of the Afghanistan National Institute of Music’s star cellist, Meena Karimi, to the Interlochen Center for the Arts in Michigan, United States.

Elizabeth H. Weatherman and Mr. Duncan, co-heads of The Romulus T. Weatherman Foundation said: “It is with great pleasure that we welcome these deserving people to the beauty and safety of Portugal and introduce them to the generous Portuguese people.”

Weatherman and Duncan also said: “Today’s great news is tempered by the bittersweet reality that there are literally hundreds of people we were forced to exclude from these flights. Those hundreds represent just a small fraction of the tens of thousands of deserving people desperate to escape Afghanistan. Without government funding, facilitation and assets it will be impossible to help the thousands of at-risk Afghans seeking to evacuate. There is currently nowhere near enough funding allocated for the resettlement of Afghans in the United States or the European Union. There are too many Afghans for private foundations, such as ours, or the overextended non-governmental organizations, to save and resettle them all. The children of Afghanistan are innocents, and the government of the United States has a moral obligation to ensure their safety and create a better future for them. We have tried to do the right thing on behalf of ourselves and our country, but we know there is much more work to be done.”

On behalf of The Foundation, Mr. Duncan has extended his heartfelt gratitude to the senior leadership of the Portuguese Government, the Embassy of the United States of America in Portugal, in particular Embassy Public Affairs Officer, Penny Rechkemmer and the staff and volunteers of Jesuit Refugee Service Portugal. The Foundation would like to specifically acknowledge the Country Director of JRS Portugal, André Costa-Jorge, and Advocacy Officer Carmo Belford.

JRS Portugal’s André Costa Jorge stated: “We know from experience that when civil society and government unite, hundreds of lives can be saved. And we also know, from our experience, that when we give the hand to the one who is alone or separated from their family, when we accompany and amplify their voices, we are building a true culture of encounter, the only basis for an authentic and lasting solidarity that unites us as beings who are part of a larger family: the human family. We would like to thank Mr. Andrew Duncan, the Weatherman family, the Portuguese government and to all the people who made it possible, for giving us hope for humanity and for saving all these lives.”

Camo Belford also says “We could not be more proud of our country, that once again showed to be on the right side of history, and of all the Portuguese diplomats who honor the legacy of Aristides de Sousa Mendes, Carlos Sampaio Garrido and so many other Portuguese heroes who during World War II saved more than 60,000 people, mostly Jews. We accompanied all the afghan families welcomed in Portugal. We know their anguish closely and feel them as if they were our own, for that is our nature. For this reason, we decided that we could not remain indifferent and that it was our role to fight for all those who would have been left behind, seeking to bring some Peace to these families and honor our mission.”

The Foundation would like to thank Senator Marco Rubio (R-FL) and his staff – both in Washington and Florida – for his office’s considerable ongoing constituency services. The foundation would also like to thank Heather Barr, associate director of the Women’s Rights Division at Human Rights Watch. Lastly, The Foundation would like to thank Robert McCreary, a former senior U.S. government official who worked with American Special Operations in Afghanistan and Farkhunda Muhtaj of Ontario,Canada for her commitment to these efforts.

The Romulus T. Weatherman Foundation has made a significant contribution to JRS Portugal to ensure the support of each of the families as they resettle in Portugal. André Costa Jorge added “We could not fail to note the outstanding spirit of collaboration that we have felt from all the public bodies involved, and to highlight the special commitment shown by the Portuguese Ministry of Foreign Affairs, the Ministry of Defence, the State Secretariat for Integration and Migration, the Presidency of the Council of Ministers and the High Commissioner for Migration, which helped us make all of this possible.”

About the Jesuit Refugee Service
The Jesuit Refugee Service (JRS) is an international Catholic non-governmental organization, founded in 1980 by the Society of Jesus. The mission of JRS is to accompany, serve and advocate the cause of refugees and forcibly displaced persons worldwide. JRS is present in about 50 countries, serving and accompanying more than 500,000 migrants every year. In Portugal, JRS was established in 1992.

About the Romulus T. Weatherman Foundation
The Romulus T. Weatherman Foundation was established by Elizabeth H. Weatherman and Andrew P. Duncan. The Foundation is dedicated to protecting human rights and democracy around the world.

About Elizabeth H. Weatherman
Ms. Weatherman is a retired executive at Warburg Pincus in New York where she led the Healthcare Group as part of the Executive Management Group. Ms. Weatherman is currently on the Board of Trustees of Stanford University and Mount Holyoke College.

About Andrew P. Duncan
Mr. Duncan is a retired technology executive, human rights advocate and award-winning film producer. Mr. Duncan owns and produced the Oscar nominated Florida Project and the Sundance Audience Award winning film Joshua: Teenager versus Superpower. Mr. Duncan has produced 11 films including Book Club, starring Jane Fonda and Candace Bergen.

Media Contact:
Marta Carvalho (JRS Portugal’s Communication Office)
+351 967 886 175
marta.carvalho@jrs.net

ADVERTISEMENT. This announcement is an advertisement for the purposes of Regulation (EU) 2017/1129, as amended (the “Prospectus Regulation”) relating to the intention of the Company to proceed with the admission to listing and trading on Euronext Milan of all Iveco Group N.V. common shares (the “Admission”). This announcement does not constitute or form part of a prospectus within the meaning of the Prospectus Regulation and has not been reviewed nor approved by any regulatory or supervisory authority in any jurisdiction, including any member state of the European Economic Area (each, an “EEA Member”), the United Kingdom and the United States. This announcement is for information purposes only and is not intended to constitute, and should not be construed as, an offer by or invitation by or on behalf of, the Company, CNH Industrial N.V. (“CNH Industrial”), any of their advisors or any representative of the Company or CNH Industrial or any of their advisors, to purchase any securities or an offer to sell or issue, or the solicitation to buy securities by any person in any jurisdiction, including any EEA Member, the United Kingdom or the United States. The approval of the Prospectus (as defined below) by the Netherlands Authority for the Financial Markets (Autoriteit Financiële Markten, the “AFM”) should not be understood as an endorsement of the quality of the Shares (as defined below) and the Company. Potential investors should read the Prospectus before making an investment decision in order to fully understand the potential risks and rewards associated with the decision to invest in the Shares.

London, November 16, 2021

CNH Industrial (NYSE: CNHI/ MI: CNHI) announced today that in view of the spin-off in early 2022, there will be an Iveco Group Investor Day on Thursday, November 18, 2021.

A live streaming of the Iveco Group Investor Day will begin at 2:30 p.m. CET / 1:30 p.m. GMT / 8:30 a.m. EST on Thursday, November 18, 2021.

The entire event is scheduled to last 2 hours, including the Q&A session.

Details for accessing the live streaming presentation and Q&A are available at the following address: https://edge.media-server.com/mmc/p/b8oerjdw

For those unable to participate in the live session, a replay will remain archived in the Iveco Group N.V. website (www.ivecogroup.com).

CNH Industrial N.V. (NYSE: CNHI / MI: CNHI) is a global leader in the capital goods sector with established industrial experience, a wide range of products and a worldwide presence. Each of the individual brands belonging to the Company is a major international force in its specific industrial sector: Case IH, New Holland Agriculture and Steyr for tractors and agricultural machinery; Case and New Holland Construction for earth moving equipment; Iveco for commercial vehicles; Iveco Bus and Heuliez Bus for buses and coaches; Iveco Astra for quarry and construction vehicles; Magirus for firefighting vehicles; Iveco Defence Vehicles for defence and civil protection; and FPT Industrial for engines and transmissions. More information can be found on the corporate website: www.cnhindustrial.com

Contacts:

Corporate Communications
Email: mediarelations@cnhind.com

Investor Relations
Email: investor.relations@cnhind.com

DISCLAIMER
This announcement does not constitute a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, as amended (the “Prospectus Regulation”), and shares in Iveco Group N.V. will be allotted in circumstances that do not constitute “an offer to the public” within the meaning of the Prospectus Regulation. This announcement is not intended for distribution in jurisdictions that require prior regulatory review and authorization to distribute an announcement of this nature.
The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions.
This announcement is an advertisement and not a prospectus within the meaning of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, as amended (the “Prospectus Regulation”). With respect to the member States of the European Economic Area, no action has been undertaken or will be undertaken to make an offer to the public of the securities referred to herein requiring a publication of a prospectus in any relevant member State. As a result, the securities may not and will not be offered in any relevant member State except pursuant to a prospectus approved by the relevant market authorities in that member State or in accordance with the exemptions set forth in Article 3(2) of the Prospectus Regulation, if they have been implemented in that relevant member State, or under any other circumstances which do not require the publication of a prospectus pursuant to Article 3 of the Prospectus Regulation and/or to applicable regulations of that relevant member State. This announcement is not intended to constitute, and should not be construed as, an offer by or invitation by or on behalf of, the Company, CNH Industrial, any of its advisors or any representative of the Company or CNH Industrial or any of their advisors, to purchase any securities or an offer to sell or issue, or the solicitation to buy securities by any person in any jurisdiction, including any EEA Member, the United Kingdom or the United States.
The securities referred to herein may not be offered or sold in the United States of America absent registration or an applicable exemption from registration under the U.S. Securities Act of 1933, as amended. The Company and CNH Industrial do not intend to register all or any portion of the offering of the securities in the United States of America or to conduct a public offering of the securities in the United States of America.
This announcement does not constitute an offer of securities to the public in the United Kingdom. This announcement is being distributed to and is directed only at (i) persons who are outside the United Kingdom or (ii) persons who are investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) and (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to as “Relevant Persons”). Any investment activity to which this announcement relates will only be available to and will only be engaged with, Relevant Persons. Any person who is not a Relevant Person should not act or rely on this document or any of its contents.
The price and value of securities may go up as well as down. Persons needing advice should contact a professional adviser. Information in this announcement or any of the documents relating to the Admission and the Demerger cannot be relied upon as a guide to future performance.
The Company may decide not to go ahead with the Admission and CNH Industrial may decide not to go ahead with the Demerger and there is therefore no guarantee that the Admission and the Demerger will occur. You should not base your financial decision on this announcement. Acquiring investments to which this announcement relates may expose an investor to a significant risk of losing all of the amount invested.

Attachment

• 20211116_PR_CNH_Industrial_announce_Iveco_Group_Investor_Day

GiftChill announces they are going to be accepting Dogecoin on the e-gift card platform. Adding Dogecoin benefits the millions of Dogecoin investors looking for ways to use their cryptocurrency. GiftChill has built a successful pathway for crypto investors to convert currency for use with retailers who do not accept cryptocurrency as a form of payment.

NEW YORK, Nov. 16, 2021 (GLOBE NEWSWIRE) — GiftChill, the leading e-gift card platform, has announced that they have added Dogecoin as payment method. Dogecoin had a record-breaking leap when entrepreneur, Elon Musk, began tweeting about the currency in 2020. Dogecoin had originally been created as a joke, but after Musk began making tweets validating it as a legitimate form of payment, investors flocked. As a result, there are millions of crypto holders invested in Dogecoin hoping for ways to use it with retailers. GiftChill saw this opportunity and opened the door for all Dogecoin investors. Dogecoin holders can smoothly use their currency with retailers and gaming platforms like Nike, Xbox, Walmart, Amazon, and Steam. Every day GiftChill offers exciting new discounts on e-gift cards and continues to make new and exciting partnerships.

GiftChill allows crypto investors to purchase gift cards that are validated and sent via email with all additional information needed already included in the same message. Most e-gift cards have no expiration dates and can be used whenever the consumer wants to. Consumers have new discounts to choose from every day for a variety of retailers, and this method of conversion is convenient and trusted by cryptocurrency investors all over the world. GiftChill knew that in order to be successful in the e-gift card industry, people would have to be able to trust their platform, so they made security and gift card validation a priority. Dogecoin investors can all unite under GiftChill as their trusted cryptocurrency gift card conversion platform. To learn more about GiftChill discounted gift cards, you can contact Support@giftchill.co.uk.

Related Images

Image 1: doge coin

doge coin to be used to pay for gift cards

This content was issued through the press release distribution service at Newswire.com.

Attachment

• doge coin

SAN DIEGO and BASEL, Switzerland, Nov. 16, 2021 (GLOBE NEWSWIRE) — Bright Peak Therapeutics, Inc., a biotechnology company developing next-generation cytokine immunotherapies, today announced that it has entered into a license agreement with Livzon Mabpharm, Inc. (“Livzon”), a subsidiary company of Livzon Pharmaceutical Group, to use LZM009, Livzon’s proprietary anti-PD-1 monoclonal antibody currently in late-stage clinical trials, to develop novel PD-1 targeted immunocytokines (“PD-1 ICs”). The PD-1 ICs will be comprised of optimized cytokine payloads developed by Bright Peak conjugated to LZM009 for the treatment of a variety of cancers. PD-1 ICs are designed to selectively target and activate cytotoxic CD8+ T cells (“CTLs”) that express the inhibitory immune checkpoint PD-1 while avoiding the broad activation of other immune cells. Dual targeting of two receptors on the same CTL with a PD-1 inhibitor and a cytokine payload (cis-signaling) offers the added potential for synergistic efficacy.

Bright Peak is dedicated to creating next-generation immunotherapies that exploit the potent biological activity of cytokines while showing a significantly improved safety profile. Using Bright Peak’s unique chemical protein synthesis and engineering platform, cytokines can be precisely designed to fine-tune receptor binding, optimize efficacy, and simultaneously insert conjugation handles at any desired site in a protein. This allows for rapid conjugation of enhanced cytokines as payloads to commonly used antibodies, creating novel and proprietary “Bright Peak Immunocytokines.” One of the many advantages of Bright Peak’s technology is the ‘off-the-shelf’ ability to convert existing therapeutic antibodies into dual-targeting immunocytokines by a simple and rapid chemical process. The platform also readily enables the screening of various cytokine payloads with differential properties to elicit the desired biological effects. Moreover, Bright Peak’s approach allows the use of antibodies ‘as-is,’ avoiding the complex process of generating recombinant antibody-cytokine fusion proteins which involves lengthy protein expression, optimization and cell-line development.

“We are delighted to license Livzon’s anti-PD-1 monoclonal antibody LZM009 to broadly develop PD-1 directed immunocytokines by leveraging our proprietary platform technology,” said Fredrik Wiklund, President and Chief Executive Officer of Bright Peak. “PD-1 inhibitors have changed the landscape of cancer therapy in recent years. However, despite the remarkable efficacy observed in a subset of patients treated with PD-1 inhibitors, most patients do not respond. Bright Peak’s PD-1 ICs have the potential to enhance the activity of PD-1 inhibition to bring the promise of immunotherapy to a greater number of patients.”

“We are excited to apply the power and versatility of our synthetic protein engineering platform to generate PD-1 ICs by conjugating optimized cytokine payloads to a clinical stage antibody. PD-1 ICs are designed to utilize the concept of cis-signaling cytokines acting on the same cell that is targeted by the anti-PD-1 antibody. As a result, they are more potent and selective and have an increased capacity to induce superior CD8+ T cell responses,” said Bertolt Kreft, Ph.D., Chief Scientific Officer of Bright Peak.

“Livzon’s PD-1 molecule has proprietary patents with broad application potential, and we are very happy to enter into an agreement with Bright Peak who possesses an innovative conjugation and protein engineering technology platform to explore and achieve dual-targeting effects of novel molecules to benefit patients with unmet medical needs,” said Jianing Liu, Ph.D., Chief Investment Officer and Head of BD of Livzon Pharmaceutical Group. “Livzon Mabpharm is more than happy to support innovative global R&D with inspiring partners leveraging on our existing pipelines and experience in biologics, and we believe this is one step further to demonstrate Livzon MabPharm’s capabilities and readiness for global outreach,” said Jiaming Yang, Ph.D., Executive Vice President of Livzon Mabpharm, Inc.

Under the terms of the license agreement, Bright Peak will receive the right to develop, manufacture and commercialize PD-1 ICs on a worldwide basis while Livzon retains certain rights of first negotiation to obtain exclusivity in the greater China territory. Livzon will receive a one-time upfront cash payment from Bright Peak and is eligible to receive additional cash payments upon the achievement of future development and regulatory milestones, as well as royalties in the low-to-mid single digit percentage range on worldwide net sales. Bright Peak will solely control and fund all activities related to development and commercialization on a worldwide basis, subject to Livzon’s right of first negotiation in greater China.

About LZM009
LZM009 is a human IgG4 monoclonal antibody which binds to PD-1 molecules on the surface of T-cells, blocks the PD-1/ PD-Ligand 1 (PD-L1) pathway and reactivates T cells to kill cancer cells. LZM009 has been approved for clinical trials and completed clinical dose exploration trials in both China and the United States. LZM009 is undergoing extensive clinical trials, including pivotal trials in thymic cancer in China, with promising initial safety and efficacy data.

About Bright Peak
Bright Peak is a privately held biotechnology company based in San Diego, USA and Basel, Switzerland dedicated to creating next-generation cytokine immunotherapies for the treatment of patients with cancer and autoimmune disease. Bright Peak is pioneering a novel technology to chemically synthesize enhanced and conjugatable cytokines that exploits the potent biological activity of cytokines while avoiding the severe side effects associated with first-generation therapies. Bright Peak’s enhanced cytokines can be easily conjugated to a diverse array of molecules, such as monoclonal antibodies, creating a novel class of “Bright Peak Immunocytokines.” Bright Peak is funded by a syndicate of leading healthcare investors.

About Livzon MabPharm and Livzon Pharmaceutical Group
Livzon MabPharm, a subsidiary company of Livzon Pharmaceutical Group, was founded in 2010, and specialized in R&D of innovative antibody drugs, fusion/ recombinant protein drugs, and other novel biologics in immune oncology, reproduction and autoimmune diseases. The company has a mature and diversified product pipeline. The company has launched a rHCG biosimilar product, and obtained BLA approval for IL6R McAb biosimilar in China. The company’s proprietary Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) has entered multiple global Phase III clinical trials as a COVID-19 prophylaxis vaccine. The company also has a number of antibody/recombinant protein products in clinical development and cell therapy products in the preclinical/POC stage. Livzon MabPharm is equipped with strong CMC capabilities, clear product development strategy, a seasoned management team and state-of-the-art manufacturing facilities.

Livzon Pharmaceutical Group Inc., (000513.SZ, 1513.HK), a leading PRC pharmaceutical company established in 1985, is a fully-integrated pharmaceutical group with more than 8,000 employees. Livzon is principally engaged in the research and development, manufacturing, sales and distribution of active pharmaceutical ingredients, small molecules, biologics, traditional Chinese medicine as well as diagnostic products in various therapeutic areas including oncology, reproduction and gynecology, gastroenterology, anti-infection, neurology and endocrinology.

Contact:
info@brightpeaktx.com